Product nameAnti-SARS spike glycoprotein antibody - N-terminal
See all SARS spike glycoprotein primary antibodies
DescriptionRabbit polyclonal to SARS spike glycoprotein - N-terminal
Tested applicationsSuitable for: ELISAmore details
Synthetic peptide corresponding to SARS spike glycoprotein (N terminal).
Database link: P59594
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle.
Storage bufferPreservative: 0.02% Sodium azide
Concentration information loading...
PurityImmunogen affinity purified
Our Abpromise guarantee covers the use of ab252691 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|ELISA||Use at an assay dependent concentration.
ab252691 will detect 10 ng of free peptide at 1 µg/mL.
RelevanceA novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive stranded RNA approximately 27 to 31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.
- E2 antibody
- E2 glycoprotein antibody
- Human coronavirus spike glycoprotein antibody
ab252691 has not yet been referenced specifically in any publications.